The percentage of active cases of Covid-19 is falling on a daily basis hinting that the worst could be over for the city.
Mehsud designated as global terrorist by UN
In a major blow to Pakistan, the United Nations on Thursday (local time) designated Pakistan-based terror organisation Tehrik-e Taliban’s Pakistan (TTP) leader, Mufti Noor Wali Mehsud, as a global terrorist.
US Covid-19 cases surpass 3.5 million
The number of Covid-19 cases in the US surpassed 3.5 million on Thursday, reaching 3,533,317, according to the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University.
Trump to issue travel ban for Chinese Communists
The Trump administration is considering banning travel to the United States by all members of the Chinese Communist Party and their families, a person familiar with the matter said on Thursday, a move that would worsen already tense US-China relations.
HCL chairman Shiv Nadar steps down
HCL Technologies today posted 31.7 per cent rise in consolidated net profit at Rs 2,925 crore for the June 2020 quarter, and said that Shiv Nadar has stepped down from the chairman’s role.
Rajnath Singh visits Leh amid India-China stand-off
Defence Minister Rajnath Singh reached Leh tday on a day-long visit to carry out a comprehensive review of the security scenario in the region in wake of the border row with China.
Two terrorists killed in encounter in Jammu & Kashmir
Two terrorists were killed in an encounter with security forces in Kulgam district of Jammu and Kashmir today.
Instead of fighting Covid, Modi govt conspiring to grab power: Cong leader
Amid the political crisis in Rajasthan, a senior Congress leader has said Prime Minister Narendra Modi-led government and BJP are ‘conspiring’ to grab power instead of fighting coronavirus pandemic.
Amitabh says ‘hospital protocol is restrictive’
Veteran Bollywood actor Amitabh Bachchan, who is getting treatment for Covid-19, has said he was not able to reveal more about his health due to hospital protocols.
Hydroxychloroquine ineffective against mild Covid-19: Study
A study conducted by researchers at the University of Minnesota has claimed that the anti-malaria drug touted by US President Donald Trump as a Covid-19 treatment was ineffective for patients with a mild version of the disease.